Jornal Brasileiro de Nefrologia is a distinguished open-access journal published by the Sociedade Brasileira de Nefrologia, catering to the dynamic field of nephrology. Since its inception, the journal has been a vital platform for disseminating cutting-edge research, clinical practices, and advancements in nephrology, particularly focusing on the Brazilian healthcare context. With an E-ISSN of 2175-8239, the journal has embraced open-access policies since 2009, promoting wider reach and accessibility for its readership. Operating out of São Paulo, Brazil, the journal holds a Q3 ranking in Nephrology as of 2023 and has contributed significantly to the academic landscape by showcasing innovative studies and discussions that shape nephrology practice. The journal not only serves as a resource for researchers but also supports nephrologists, clinicians, and students in their pursuit of knowledge, ensuring that critical developments in kidney health are shared widely. With annual publication cycles from 2010 to 2024, the Jornal Brasileiro de Nefrologia remains committed to advancing the discipline while engaging an international audience dedicated to improving patient care in nephrology.

Canadian Journal of Kidney Health and Disease, published by SAGE Publications Inc, is a leading open-access journal dedicated to advancing the field of nephrology. Established in 2014, the journal aims to bridge the gap between research and clinical practice by disseminating high-quality clinical and experimental research findings, reviews, and case studies that focus on kidney health and associated disorders. With an impressive impact factor and ranked in the Q2 category for nephrology, the journal fosters an environment for interdisciplinary collaboration and innovation, enhancing the visibility of crucial advancements in kidney disease research. As an open-access journal, it ensures that valuable knowledge is accessible to researchers, healthcare professionals, and students globally, facilitating a deeper understanding of kidney health issues and promoting improved patient care. Located in the United Kingdom, the journal continues to expand its reach and influence within the nephrology community, leveraging its open-access model to encourage a diverse audience in exploring cutting-edge findings and sharing insights pertinent to kidney health.

The Indian Journal of Nephrology is a premier Open Access publication dedicated to advancing the field of nephrology. Published by Wolters Kluwer Medknow Publications since 2007, this journal has become a vital resource for researchers, clinicians, and students alike, providing them with a platform to disseminate innovative research findings and clinical perspectives in kidney health. With an ISSN of 0971-4065 and E-ISSN of 1998-3662, the journal plays a significant role in the dissemination of knowledge in the nephrology community, especially in India. Despite its Q3 ranking in nephrology according to the 2023 Category Quartiles, the journal reaches a diverse audience through its extensive Open Access model, promoting visibility and accessibility for all contributors. The converged years from 2009 to 2024 reflect its ongoing commitment to publishing impactful and relevant research, thus reinforcing its importance as a reliable source for the evolution of nephrological studies.

The American Journal of Kidney Diseases, published by W B Saunders Co-Elsevier Inc, stands as a premier academic resource in the field of nephrology, with an impressive impact factor that highlights its significance in advancing kidney health research. Since its inception in 1981, this journal has consistently provided a platform for innovative studies and critical reviews that shape clinical practices and policies in kidney disease management, achieving a prestigious Q1 ranking within the nephrology category as of 2023. With an H-index reflective of its research dynamism and influence, the journal has become an essential read for professionals, researchers, and students keen on the latest scientific advancements. While the journal does not offer Open Access, it continues to maintain high standards for the quality and relevance of its published content, making it indispensable for those dedicated to understanding and combating kidney diseases. Its address is located in Philadelphia, PA, further solidifying its commitment to fostering knowledge in the United States and beyond.

Kidney Medicine is a pioneering Open Access journal dedicated to advancing the field of nephrology and internal medicine, published by Elsevier. Since its inception in 2019, it has rapidly established itself as a vital resource, currently ranked in the Q2 category for Internal Medicine and Q1 for Nephrology by 2023, reflecting its influence and critical contributions to both disciplines. With an impressive Scopus ranking, positioning it at #24 out of 81 in Nephrology, the journal serves as an essential platform for researchers, clinicians, and students eager to disseminate and access high-quality research. By providing open access to a diverse array of articles, Kidney Medicine ensures that vital research reaches a wide audience, thereby facilitating knowledge exchange and innovation within the community. Its ongoing commitment to excellence and relevance makes it a key player in shaping the future of kidney health worldwide.

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

NEPHRON is a premier peer-reviewed academic journal dedicated to advancing the field of nephrology and renal medicine. Published by KARGER, renowned for its commitment to quality research, NEPHRON serves as a vital resource for researchers, clinicians, and students interested in the latest findings and developments in kidney health. With an ISSN of 1660-8151 and an E-ISSN of 2235-3186, the journal ensures wide accessibility and dissemination of knowledge in the renal domain. Although specific impact metrics such as the HIndex are presently unavailable, NEPHRON's emphasis on Open Access publishing greatly enhances its visibility and accessibility, allowing groundbreaking research to reach a global audience. Through a comprehensive scope that encompasses clinical studies, basic research, and translational science, NEPHRON contributes significantly to the understanding and treatment of kidney diseases. Join the vibrant community of professionals and scholars who are shaping the future of nephrology by engaging with the wealth of knowledge presented in NEPHRON.

NEPHROLOGY DIALYSIS TRANSPLANTATION is a premier academic journal published by Oxford University Press that plays a vital role in disseminating cutting-edge research within the fields of nephrology and transplantation. With an impressive impact factor and recognition as Q1 in both these categories for 2023, the journal ranks among the top publications in medicine, enhancing its visibility among a global audience of researchers, healthcare professionals, and students. Established in 1986, the journal has maintained a commitment to publishing high-quality, peer-reviewed articles that contribute to the advancement of knowledge and practice in renal medicine. Although this journal does not offer open access options, it remains a highly regarded resource due to its rigorous selection process and influential contributions to the field. Scholars are encouraged to explore the journal’s extensive archive, spanning from 1986 to 2024, for invaluable insights and developments in nephrology and transplantation.

Kidney International Supplements is a prestigious academic journal published by Elsevier Science Inc, specializing in the field of nephrology. With an impressive impact factor and ranked in the top percentile, it holds the esteemed position of Q1 in nephrology categories, reflecting its influential contribution to the academic community. Throughout its publication history from 2011 to 2022 and in the anticipated 2024 edition, the journal has provided a vital platform for disseminating high-quality research and insights, catering to professionals, researchers, and students dedicated to advancing kidney health. While it offers traditional access options, the journal is committed to promoting the highest standards of research integrity and innovation in nephrology. The journal plays an essential role in shaping the future of kidney disease treatment, levelling knowledge exchange across specialties, and fostering collaboration among experts in the field.

Nephrologie & Therapeutique is a distinguished peer-reviewed journal published by JOHN LIBBEY EUROTEXT LTD, dedicated to the field of nephrology. Since its inception in 2005, this journal has been pivotal in disseminating high-quality research in the areas of kidney disease, renal therapies, and nephrological advancements, and it continues to serve as an essential resource for professionals, researchers, and students alike. With an ISSN of 1769-7255 and an E-ISSN of 1872-9177, the journal is indexed in Scopus and is currently ranked in the third quartile (Q3) within the nephrology category, showing significant contributions to the discipline, despite its current ranking of 64 out of 81. Although Nephrologie & Therapeutique does not operate under an open access model, it nevertheless provides valuable insights and updates on the latest findings and practices in nephrology, making it an important platform for academic discourse in this field. The journal's commitment to advancing knowledge and fostering interdisciplinary dialogue underscores its role as a key player in shaping future research and clinical practices in nephrology.